DK1313712T3 - Fremgangsmåde og mellemforbindelser til fremstilling af retrovirale proteaseinhibitorer - Google Patents
Fremgangsmåde og mellemforbindelser til fremstilling af retrovirale proteaseinhibitorerInfo
- Publication number
- DK1313712T3 DK1313712T3 DK01966367T DK01966367T DK1313712T3 DK 1313712 T3 DK1313712 T3 DK 1313712T3 DK 01966367 T DK01966367 T DK 01966367T DK 01966367 T DK01966367 T DK 01966367T DK 1313712 T3 DK1313712 T3 DK 1313712T3
- Authority
- DK
- Denmark
- Prior art keywords
- intermediates
- preparation
- protease inhibitors
- retroviral protease
- amino
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 230000001177 retroviral effect Effects 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- AIDS & HIV (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65191900A | 2000-08-31 | 2000-08-31 | |
| PCT/US2001/026898 WO2002018349A2 (en) | 2000-08-31 | 2001-08-29 | Process and intermediates for preparing retroviral protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1313712T3 true DK1313712T3 (da) | 2007-09-10 |
Family
ID=24614772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01966367T DK1313712T3 (da) | 2000-08-31 | 2001-08-29 | Fremgangsmåde og mellemforbindelser til fremstilling af retrovirale proteaseinhibitorer |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1313712B1 (da) |
| JP (1) | JP5021141B2 (da) |
| KR (1) | KR100806533B1 (da) |
| CN (1) | CN1264823C (da) |
| AT (1) | ATE361913T1 (da) |
| AU (1) | AU2001286889A1 (da) |
| BR (1) | BR0108146A (da) |
| CA (2) | CA2731273C (da) |
| CY (1) | CY1106738T1 (da) |
| DE (1) | DE60128367T2 (da) |
| DK (1) | DK1313712T3 (da) |
| ES (1) | ES2284684T3 (da) |
| IL (1) | IL153436A0 (da) |
| MX (1) | MXPA03001751A (da) |
| PT (1) | PT1313712E (da) |
| WO (1) | WO2002018349A2 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2378669T3 (es) * | 2003-12-11 | 2012-04-16 | Abbott Laboratories | Compuestos inhibidores de proteasa de VIH |
| CN100358521C (zh) * | 2004-12-28 | 2008-01-02 | 哈尔滨欧替药业股份有限公司 | 一种双唑泰栓剂及其制备工艺 |
| CN103910634B (zh) * | 2012-12-29 | 2018-04-27 | 广东东阳光药业有限公司 | 西格列汀中间体的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5914332A (en) * | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
-
2001
- 2001-08-29 CA CA2731273A patent/CA2731273C/en not_active Expired - Lifetime
- 2001-08-29 AU AU2001286889A patent/AU2001286889A1/en not_active Abandoned
- 2001-08-29 JP JP2002523467A patent/JP5021141B2/ja not_active Expired - Lifetime
- 2001-08-29 EP EP01966367A patent/EP1313712B1/en not_active Expired - Lifetime
- 2001-08-29 IL IL15343601A patent/IL153436A0/xx active IP Right Grant
- 2001-08-29 CN CNB018148646A patent/CN1264823C/zh not_active Expired - Lifetime
- 2001-08-29 BR BR0108146-2A patent/BR0108146A/pt not_active Application Discontinuation
- 2001-08-29 DE DE60128367T patent/DE60128367T2/de not_active Expired - Lifetime
- 2001-08-29 CA CA2416955A patent/CA2416955C/en not_active Expired - Lifetime
- 2001-08-29 MX MXPA03001751A patent/MXPA03001751A/es active IP Right Grant
- 2001-08-29 ES ES01966367T patent/ES2284684T3/es not_active Expired - Lifetime
- 2001-08-29 AT AT01966367T patent/ATE361913T1/de active
- 2001-08-29 DK DK01966367T patent/DK1313712T3/da active
- 2001-08-29 KR KR1020037002869A patent/KR100806533B1/ko not_active Expired - Lifetime
- 2001-08-29 PT PT01966367T patent/PT1313712E/pt unknown
- 2001-08-29 WO PCT/US2001/026898 patent/WO2002018349A2/en not_active Ceased
-
2007
- 2007-07-16 CY CY20071100952T patent/CY1106738T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2731273A1 (en) | 2002-03-07 |
| CA2731273C (en) | 2013-10-15 |
| PT1313712E (pt) | 2007-07-25 |
| CA2416955C (en) | 2011-04-26 |
| EP1313712B1 (en) | 2007-05-09 |
| KR20030061787A (ko) | 2003-07-22 |
| WO2002018349A2 (en) | 2002-03-07 |
| JP5021141B2 (ja) | 2012-09-05 |
| ES2284684T3 (es) | 2007-11-16 |
| CY1106738T1 (el) | 2012-05-23 |
| IL153436A0 (en) | 2003-07-06 |
| AU2001286889A1 (en) | 2002-03-13 |
| CA2416955A1 (en) | 2002-03-07 |
| WO2002018349A3 (en) | 2002-05-10 |
| HK1057040A1 (en) | 2004-03-12 |
| JP2004507528A (ja) | 2004-03-11 |
| MXPA03001751A (es) | 2003-09-10 |
| CN1449388A (zh) | 2003-10-15 |
| CN1264823C (zh) | 2006-07-19 |
| EP1313712A2 (en) | 2003-05-28 |
| DE60128367T2 (de) | 2008-01-10 |
| KR100806533B1 (ko) | 2008-02-25 |
| ATE361913T1 (de) | 2007-06-15 |
| DE60128367D1 (de) | 2007-06-21 |
| BR0108146A (pt) | 2004-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03005219A (es) | Peptidos diarilicos como inhibidores de ns3-serina proteasa en hepatitis de virus c. | |
| BR0215405A (pt) | Composições e processos de uso de collajolie | |
| NO20035488D0 (no) | HV-protease-inhibitorer, blandinger inneholdende disse, deres farmas degree ytiskeanvendelser og materialer for deres syntese | |
| DK1171417T3 (da) | Fremgangsmåde til fremstilling af 3-aryloxy-3-arylpropylaminer og mellemprodukter deraf | |
| TR200103390T2 (tr) | Proteaz inhibitörleri olan yeni bileşikler ve terkipler. | |
| DK1362052T3 (da) | Inhibitorer af cruzipain og andre cysteinproteaser | |
| SE0002102D0 (sv) | Chemical compound | |
| DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
| TR200003028T2 (tr) | Yeni ikame edilmiş amidler, bunların üretimi ve kullanımı. | |
| DK1456212T3 (da) | 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse | |
| DE60215623D1 (de) | Breitspektrum 2-(substituierte-amino)-benzothiazol-sulfonamide hiv protease inhibitoren | |
| DK1017684T3 (da) | Kontrastmiddel til afbildning af infarkter og nekroser | |
| MXPA04004805A (es) | Peptido novedoso que tiene un efecto inhibidor de la enzima convertidora de angiotensina. | |
| BR0312889A (pt) | Polipeptìdeo t20 peguilado | |
| DK0804410T3 (da) | Fremgangsmåde til fremstilling af retrovirale proteaseinhibitor-mellemprodukter | |
| ATE433458T1 (de) | Modulatoren von ship-1 | |
| DK1299429T3 (da) | Scavengerharpiks og fremgangsmåder til anvendelse deraf | |
| DK1313712T3 (da) | Fremgangsmåde og mellemforbindelser til fremstilling af retrovirale proteaseinhibitorer | |
| IS2273B (is) | Aðferð fyrir nýsmíðina á HIV próteasa lötum | |
| EA200400392A1 (ru) | Связывающий каспазу-8 белок, его получение и применение | |
| BR0316544A (pt) | Compostos calcilìticos | |
| DK1318142T3 (da) | t-butoxycarbonylaminoethylamin til syntese af PNA-monomerenheder, aminosyrederivater, mellemprodukter deraf og fremgangsmåder til fremstilling af disse | |
| NO20024679D0 (no) | Krystallinsk farmasöytikum | |
| TR200100906T2 (tr) | Trombin inhibitörleri olarak benzamid türevleri | |
| WO2003097593A3 (en) | Protease inhibitors |